Concomitant pharmacotherapy overcomes immunotherapy challenges in aggressive blood cancer

[Educator]

Researchers at the University of Zurich and the University Hospital Zurich have discovered that a specific mutation in the cancer cells of an aggressive type of blood cancer can prevent novel immunotherapies such as CAR T-cell therapy from working.